Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004959706 | SCV005469236 | uncertain significance | Inborn genetic diseases | 2024-08-27 | criteria provided, single submitter | clinical testing | The c.2519C>T (p.P840L) alteration is located in exon 18 (coding exon 18) of the PIEZO2 gene. This alteration results from a C to T substitution at nucleotide position 2519, causing the proline (P) at amino acid position 840 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |